Medical Thawing Device Delivers Plasma on Demand
By HospiMedica International staff writers Posted on 14 Jan 2020 |

Image: The ZipThaw device thaws plasma rapidly and safely (Photo courtesy of FreMon Scientific)
A portable rapid warming device thaws fresh frozen plasma (FFP) and plasma frozen within 24 hours after phlebotomy (FP24) for clinical use.
The FreMon Scientific (La Jolla, CA, USA) ZipThaw device is a lightweight (eight kilograms), compact precision plasma thawing system that is designed to rapidly thaw FFP and FP24 at the point of care, be it the operating room, procedure room, at the bedside, or in a trauma location. The device plugs into a standard outlet and has two chambers which work independently. Fear of cross contamination is minimized via the leakproof ZipSleeve, a disposable, durable, blood product sleeve that eliminates concerns of bursting bags, and also contains a warming technology that enables consistent temperature of the final product.
Features include dry electronic circuits, with no water immersion needed; preservation of coagulation factors needed for transfusion; a touch screen with a user friendly interface; the device is maintenance free, eliminating the risk of rupture and cross contamination; blood products temperature is consistently monitored, with no recalibration needed; continuous data capture and report of the full thawing cycle is provided; an integrated barcode reader promotes freezer-to-vein tracking; whisper quiet operation; and a three-year full replacement warranty.
“ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve's patented sensors, the system gives accurate, degree-by-degree measurement of the specimen's actual temperature during the thawing process, not its surroundings,” said Farideh Bischoff, MD, CEO of FreMon Scientific. “FreMon Scientific has designed the next generation thawing device. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible, and safe.”
Blood plasma is a yellowish-colored liquid component of blood in which blood cells are suspended, making it the “extracellular matrix” of blood cells. Along with platelets, plasma serves an important function and thanks to clotting factors, helps repair damage to blood vessels and stanching bleeding. FFP can be kept at -25°C or lower for up to three years, and can be used for five days after thawing. Civilian and military clinical practice guidelines call for early transfusion of plasma in cases of severe trauma and hemorrhagic shock so as to achieve a plasma-to-red-blood-cell ratio of 1:1 to 1:2.
Related Links:
FreMon Scientific
The FreMon Scientific (La Jolla, CA, USA) ZipThaw device is a lightweight (eight kilograms), compact precision plasma thawing system that is designed to rapidly thaw FFP and FP24 at the point of care, be it the operating room, procedure room, at the bedside, or in a trauma location. The device plugs into a standard outlet and has two chambers which work independently. Fear of cross contamination is minimized via the leakproof ZipSleeve, a disposable, durable, blood product sleeve that eliminates concerns of bursting bags, and also contains a warming technology that enables consistent temperature of the final product.
Features include dry electronic circuits, with no water immersion needed; preservation of coagulation factors needed for transfusion; a touch screen with a user friendly interface; the device is maintenance free, eliminating the risk of rupture and cross contamination; blood products temperature is consistently monitored, with no recalibration needed; continuous data capture and report of the full thawing cycle is provided; an integrated barcode reader promotes freezer-to-vein tracking; whisper quiet operation; and a three-year full replacement warranty.
“ZipThaw delivers plasma to patients requiring transfusions, and with ZipSleeve's patented sensors, the system gives accurate, degree-by-degree measurement of the specimen's actual temperature during the thawing process, not its surroundings,” said Farideh Bischoff, MD, CEO of FreMon Scientific. “FreMon Scientific has designed the next generation thawing device. Today marks a new era in plasma thawing for patients, clinicians, and researchers seeking a more effective approach that is efficient, reproducible, and safe.”
Blood plasma is a yellowish-colored liquid component of blood in which blood cells are suspended, making it the “extracellular matrix” of blood cells. Along with platelets, plasma serves an important function and thanks to clotting factors, helps repair damage to blood vessels and stanching bleeding. FFP can be kept at -25°C or lower for up to three years, and can be used for five days after thawing. Civilian and military clinical practice guidelines call for early transfusion of plasma in cases of severe trauma and hemorrhagic shock so as to achieve a plasma-to-red-blood-cell ratio of 1:1 to 1:2.
Related Links:
FreMon Scientific
Latest Critical Care News
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
- Starfish-Inspired Wearable Tech Enables Smarter Heart Monitoring
- AI Eye Scans Could Help Identify Heart Disease and Stroke Risk
Channels
Surgical Techniques
view channel
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more